To evaluate the safety and efficacy of Thulasi ennai for the treatment of soolikanam(Bronchial asthma in children)
Phase 2
- Conditions
- Health Condition 1: J454- Moderate persistent asthma
- Registration Number
- CTRI/2019/11/022130
- Lead Sponsor
- S Sonitha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Cough without expectoration
Dyspnoea
Running nose
chest tightness
wheezing
Exclusion Criteria
Primary complex
Hypersensitivity pneumonitis
Lung abscess
Cystic fibrosis
Bronchiolitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the therapeutic efficacy of the Siddha herbal medicineTHULASI ENNAIin the treatment of SoolikanamTimepoint: The efficacy of the drug in pediatric bronchial asthma in 6-12 year age group
- Secondary Outcome Measures
Name Time Method To assess and compare the symptoms before and after treatmentTimepoint: compare before and after treatment